Skip to main content

Abaloparatide Pregnancy and Breastfeeding Warnings

Brand names: Tymlos

Medically reviewed by Drugs.com. Last updated on Jan 20, 2023.

Abaloparatide Pregnancy Warnings

This drug is not indicated for use in females of reproductive potential

US FDA pregnancy category: Not assigned

Risk summary: No data available on the use of this drug in pregnant women to inform a drug-related risk.

Animal reproduction studies have not been conducted. There are no controlled data in human pregnancy.

See references

Abaloparatide Breastfeeding Warnings

This drug is not indicated for use in females of reproductive potential

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments: There is no information on the presence of this drug in human milk, the effects on the breastfed infant, or the effects on milk production.

See references

See also

References for pregnancy information

  1. (2017) "Product Information. Tymlos (abaloparatide)." Radius Health

References for breastfeeding information

  1. (2017) "Product Information. Tymlos (abaloparatide)." Radius Health

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer